DEATH PANELS ?
Whether one supports or opposes the Affordable Health Care Act or not, detractors focus on the notion of committees that will determine what therapy or procedure is justifiable or not. They have been referred to as “death panels”- denying care to those who need it and thereby letting them die. Seniors are up in arms with images of Soylent Green. Everyone wants every chance at life- no matter the cost!
Let me say from the outset that rationing of health care products and services is inevitable. It will make NO difference what health care plan (or unplan ) we implement and who populates the Congress or White House. There is an extraordinary amount of U.S. medicine that is wasteful, ineffective at best and often causing premature death and adversely affecting quality of life. You have heard my theme before- MORE is NOT BETTER! MORE food is not healthier. MORE X-Ray testing is not better, because it can cause cancer in and of itself. MORE antibiotics are not better because they cause resistant bacteria that we cannot treat. MORE tests find more disease, that leads to yet MORE tests, medications and procedures that lead to complications that lead to MORE disease than the original disease. All the while, MORE of this takes resources ($) from the prevention and treatment of disease we CAN address.
Cancer specialists have identified procedures that do not help patients live longer and, in fact, may be worse for the patient. The non partisan Congressional Budget Office in 2008 estimated that nearly 30 % of health care costs like hospital stays, procedures and tests that do nothing for patient health!!!!!!!!!!! The American Society of Clinical Oncology (ASCO 200 physicians strong) released a list of what it considered unnecessary. It included drugs that cost as much as $100,000, but which extended life but a few months. It pointed out imaging tests (like CT scans, PET scans, etc.) that costs thousands, but, that do not benefit patients at all. ASCO recommends against routine use of four procedures: chemotherapy for patients with advanced cancers who are unlikely to benefit; advanced imaging technologies such as CT and PET or bone scans to determine the precise stage of both early breast and prostate cancers at low risk for metastasis; and drugs to stimulate white blood cell production in patients receiving chemotherapy if they have a risk of febrile neutropenia, an often-fatal condition marked by fever and abnormally low numbers of certain white blood cells.
...
